Artemisinin CAS 63968-64-9

Artemisinin CAS 63968-64-9: Comprehensive Product Guide

Table of Contents

• Product Specifications & Comparative Analysis
• Applications & Therapeutic Uses
• Operational Protocols & Usage Guidelines
• Industry Implementation Case Studies
• Client Success Stories
• Procurement Consultation

1. Product Specifications & Comparative Analysis

2. Applications & Therapeutic Uses

2.1 Malaria Therapeutics

As WHO-recommended antimalarial compound, demonstrates parasite clearance rates exceeding 95% in plasmodium falciparum strains through peroxide bridge activation mechanism.

2.2 Oncology Research

Exhibits selective cytotoxicity in breast cancer (MCF-7) and ovarian cancer cell lines, showing 40-60% proliferation inhibition at 50μM concentrations through ROS-mediated apoptosis pathways.

2.3 Anti-Inflammatory Applications

Reduces TNF-α and IL-6 cytokine levels by 30-45% in murine models, demonstrating potential for autoimmune disorder management.

3. Operational Protocols & Usage Guidelines

3.1 Pharmaceutical Formulation

Recommended dissolution in DMSO (50mg/mL stock solution) with subsequent dilution in cell culture medium to maintain <0.1% solvent concentration.

3.2 Analytical Testing

HPLC parameters: C18 column (4.6×250mm), mobile phase acetonitrile:water (65:35), flow rate 1.0mL/min, detection wavelength 210nm.

4. Industry Implementation Case Studies

4.1 Antimalarial Drug Production

Pharmaceutical manufacturer achieved 98.7% API recovery rate through optimized crystallization process at 15-20°C temperature range.

4.2 Cancer Research Application

University research team observed 72% tumor growth inhibition in xenograft models using 100mg/kg daily oral administration over 21-day周期.

5. Client Success Stories

5.1 Vaccine Development Institute

Implemented artemisinin-based adjuvants in malaria vaccine candidates, enhancing immune response by 40% compared to conventional formulations.

5.2 Botanical Extract Company

Scaled up production to 500kg/month through optimized supercritical CO₂ extraction, maintaining >99% purity while reducing solvent costs by 35%.

6. Procurement Consultation

For batch-specific COA documentation, bulk pricing inquiries, or custom synthesis requirements:

Contact: info@vivalr.com
Tel: (86) 15866781826

Request quotation with:
– Required quantity (mg/g/kg)
– Purity specifications
– Delivery timeline
– Special packaging requirements